- Original Article
- Open access
- Published:
Palonosetron in preventing postoperative nausea and vomiting in middle ear surgery: a randomized-controlled study
The Egyptian Journal of Otolaryngology volume 29, pages 156–158 (2013)
En
Abstract
Background
This study aimed to evaluate the efficacy of palonosetron, the 5-hydroxytryptamine-3 (5-HT3) receptor antagonist, in preventing postoperative nausea and vomiting (PONV) after middle ear surgery.
Patients and methods
Sixty-two ASA I and II patients who had undergone middle ear surgery under general anesthesia were included in a double-blind, placebo-controlled study and were enrolled into two groups: palonosetron group (P) and placebo control group (C). Patients were administered 0.075 mg of palonosetron or isotonic saline, respectively. The incidence of PONV and requirement of rescue antiemetics were assessed. The severity of nausea was evaluated according to the visual analogue scale. Patients who had not experienced any attack of vomiting or received rescue drug were considered to have a complete response.
Results
The incidence of PONV was significantly lower in group P than that in the control group C during (0–4 h) P-value less than 0.001 and (4–24 h) 0.05 periods, and the incidence of complete response was 83.7% in group P and 6.5% in group C (P<0.001).
Conclusion
Palonosetron could provide effective prophylactic antiemetic control to prevent PONV after middle ear surgery under general anesthesia.
References
Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth. 1996;76:316–318.
Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anesthesia? Best Pract Res Clin Anaesthesiol. 2005;19:485–500.
Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–184.
Muchatuta NA, Paech MJ. Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manag. 2009;5:21–34.
Miller RC, Galvan M, Gittos MW, van Giersbergen PLM, Moser PC, Fozard JR. Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors. Drug Dev Res. 1993;28:87–93.
Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72- hour period. Anesth Analg. 2008;107:439–444.
Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2002;46:921–928.
Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 (Suppl 8A): 106S–112S.
Jung JS, Park JS, Kim SO, Lim DG, Park SS, Kwak KH, et al.. Prophylactic antiemetic effect of midazolam after middle ear surgery. Otolaryngol Head Neck Surg. 2007;137:753–756.
Lee DW, Lee HG, Jeong CY, Jeong SW, Lee SH. Postoperative nausea and vomiting after mastoidectomy with tympanoplasty: a comparison between TIVA with propofol-remifentanil and balanced anesthesia with sevoflurane-remifentanil. Korean J Anesthesiol. 2011;61:399–404.
Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–243.
Camu F, Lauwers MH, Verbessem D. Incidence and aetiology of postoperative nausea and vomiting. Eur J Anaesthesiol. 1992;9 (Suppl 6): 25–31.
Fujii Y, Toyooka H, Tanaka H. Granisetron in the prevention of nausea and vomiting after middle-ear surgery: a dose-ranging study. Br J Anaesth. 1998;80:764–766.
Bhattacharjee DP, Dawn S, Nayak S, Roy PR, Acharya A, Dey R. A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2010;26:480–483.
Moon YE, Joo J, Kim JE, Lee Y. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. Br J Anaesth. 2012;108:417–422.
Fujii Y, Tanaka H, Kobayashi N. Prevention of nausea and vomiting after middle ear surgery: granisetron versus ramosetron. Laryngoscope. 1999;109:1988–1990.
Oshima T, Kasuya Y, Okumura Y, Terazawa E, Dohi S. Prevention of nausea and vomiting with tandospirone in adults after tympanoplasty. Anesth Analg. 2002;95:1442–1445.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflicts of interest
There are no conflicts of interest.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elahl, M.I., Badea, M. Palonosetron in preventing postoperative nausea and vomiting in middle ear surgery: a randomized-controlled study. Egypt J Otolaryngol 29, 156–158 (2013). https://doi.org/10.7123/01.EJO.0000430965.58638.ee
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.7123/01.EJO.0000430965.58638.ee